Literature DB >> 29751008

Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Apurva S More1, Ronald T Toth1, Solomon Z Okbazghi2, C Russell Middaugh1, Sangeeta B Joshi1, Thomas J Tolbert2, David B Volkin3, David D Weis4.   

Abstract

We have used hydrogen exchange-mass spectrometry to characterize local backbone flexibility of 4 well-defined IgG1-Fc glycoforms expressed and purified from Pichia pastoris, 2 of which were prepared using subsequent in vitro enzymatic treatments. Progressively decreasing the size of the N-linked N297 oligosaccharide from high mannose (Man8-Man12), to Man5, to GlcNAc, to nonglycosylated N297Q resulted in progressive increases in backbone flexibility. Comparison of these results with recently published physicochemical stability and Fcγ receptor binding data with the same set of glycoproteins provide improved insights into correlations between glycan structure and these pharmaceutical properties. Flexibility significantly increased upon glycan truncation in 2 potential aggregation-prone regions. In addition, a correlation was established between increased local backbone flexibility and increased deamidation at asparagine 315. Interestingly, the opposite trend was observed for oxidation of tryptophan 277 where faster oxidation correlated with decreased local backbone flexibility. Finally, a trend of increasing C'E glycopeptide loop flexibility with decreasing glycan size was observed that correlates with their FcγRIIIa receptor binding properties. These well-defined IgG1-Fc glycoforms serve as a useful model system to identify physicochemical stability and local backbone flexibility data sets potentially discriminating between various IgG glycoforms for potential applicability to future comparability or biosimilarity assessments.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibody; glycosylation; hydrogen exchange; mass spectrometry; stability

Mesh:

Substances:

Year:  2018        PMID: 29751008      PMCID: PMC6089645          DOI: 10.1016/j.xphs.2018.04.026

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  65 in total

1.  Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.

Authors:  E O Saphire; P W Parren; R Pantophlet; M B Zwick; G M Morris; P M Rudd; R A Dwek; R L Stanfield; D R Burton; I A Wilson
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 2.  Immunogenicity of protein aggregates--concerns and realities.

Authors:  Wei Wang; Satish K Singh; Ning Li; Maria R Toler; Kevin R King; Sandeep Nema
Journal:  Int J Pharm       Date:  2012-04-21       Impact factor: 5.875

Review 3.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

4.  Biosimilarity Assessments of Model IgG1-Fc Glycoforms Using a Machine Learning Approach.

Authors:  Jae Hyun Kim; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin; Aaron Smalter Hall
Journal:  J Pharm Sci       Date:  2015-12-30       Impact factor: 3.534

5.  Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains.

Authors:  K R Abhinandan; Andrew C R Martin
Journal:  Mol Immunol       Date:  2008-07-09       Impact factor: 4.407

Review 6.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

7.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

8.  Minimizing carry-over in an online pepsin digestion system used for the H/D exchange mass spectrometric analysis of an IgG1 monoclonal antibody.

Authors:  Ranajoy Majumdar; Prakash Manikwar; John M Hickey; Jayant Arora; C Russell Middaugh; David B Volkin; David D Weis
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

9.  The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  MAbs       Date:  2016-08-05       Impact factor: 5.857

10.  Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity Analysis.

Authors:  Solomon Z Okbazghi; Apurva S More; Derek R White; Shaofeng Duan; Ishan S Shah; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; Thomas J Tolbert
Journal:  J Pharm Sci       Date:  2016-01-09       Impact factor: 3.534

View more
  3 in total

Review 1.  A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function.

Authors:  Yoshiki Yamaguchi; Adam W Barb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

2.  The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange.

Authors:  Felix Kuhne; Lea Bonnington; Sebastian Malik; Marco Thomann; Cecile Avenal; Florian Cymer; Harald Wegele; Dietmar Reusch; Michael Mormann; Patrick Bulau
Journal:  Antibodies (Basel)       Date:  2019-10-01

3.  Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.

Authors:  Sanjeev Agarwal; John M Hickey; Neha Sahni; Ronald T Toth; George A Robertson; Robert Sitrin; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-08-07       Impact factor: 3.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.